Akash Tewari
Stock Analyst at Jefferies
(4.73)
# 678
Out of 4,520 analysts
491
Total ratings
56.5%
Success rate
13.5%
Average return
Main Sectors:
Stocks Rated by Akash Tewari
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Maintained: Buy | $90 | $54.39 | +65.47% | 10 | Jul 15, 2026 | |
| ALKS Alkermes | Maintained: Buy | $59 → $65 | $52.72 | +23.29% | 28 | Jul 9, 2026 | |
| VRTX Vertex Pharmaceuticals | Maintained: Buy | $580 → $610 | $485.65 | +25.60% | 3 | Jul 8, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | $104 | $59.59 | +74.53% | 37 | Jul 6, 2026 | |
| LLY Eli Lilly and Company | Maintained: Buy | $1,350 | $1,179.11 | +14.49% | 45 | Jul 6, 2026 | |
| PFE Pfizer | Maintained: Buy | $34 | $25.05 | +35.73% | 44 | Jul 3, 2026 | |
| NBIX Neurocrine Biosciences | Maintained: Buy | $181 → $200 | $170.88 | +17.04% | 28 | Jun 30, 2026 | |
| SYRE Spyre Therapeutics | Maintained: Buy | $98 | $100.23 | -2.22% | 5 | Jun 30, 2026 | |
| BNTX BioNTech SE | Maintained: Buy | $138 | $91.48 | +50.85% | 37 | Jun 1, 2026 | |
| JBIO Jade Biosciences | Maintained: Buy | $16 → $40 | $20.86 | +91.75% | 2 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $180 | $134.28 | +34.05% | 2 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $750.50 | - | 3 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $3.69 | +279.40% | 1 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $885 → $890 | $676.69 | +31.52% | 35 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $350 | $366.29 | -4.45% | 2 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $980 → $1,008 | $860.55 | +17.13% | 42 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $46 | $55.92 | -17.74% | 19 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $35 | $14.75 | +137.29% | 2 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $42 | $24.19 | +73.63% | 6 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $18 → $20 | $13.74 | +45.56% | 8 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $80 | $80.18 | -0.22% | 19 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $398 → $502 | $553.48 | -9.30% | 16 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $86 → $96 | $134.00 | n/a | 4 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $138 | $127.50 | n/a | 34 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $52 → $10 | $8.01 | n/a | 8 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $68 | $60.74 | n/a | 13 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $183 | $247.53 | n/a | 18 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $2.5 | $5.11 | n/a | 7 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 → $17 | $19.91 | n/a | 7 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $1.75 | n/a | 1 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $17.29 | n/a | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $6.78 | n/a | 2 | Jan 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $9 | $32.03 | n/a | 1 | Jul 19, 2019 |
Ionis Pharmaceuticals
Jul 15, 2026
Maintained: Buy
Price Target: $90
Current: $54.39
Upside: +65.47%
Alkermes
Jul 9, 2026
Maintained: Buy
Price Target: $59 → $65
Current: $52.72
Upside: +23.29%
Vertex Pharmaceuticals
Jul 8, 2026
Maintained: Buy
Price Target: $580 → $610
Current: $485.65
Upside: +25.60%
BioMarin Pharmaceutical
Jul 6, 2026
Maintained: Buy
Price Target: $104
Current: $59.59
Upside: +74.53%
Eli Lilly and Company
Jul 6, 2026
Maintained: Buy
Price Target: $1,350
Current: $1,179.11
Upside: +14.49%
Pfizer
Jul 3, 2026
Maintained: Buy
Price Target: $34
Current: $25.05
Upside: +35.73%
Neurocrine Biosciences
Jun 30, 2026
Maintained: Buy
Price Target: $181 → $200
Current: $170.88
Upside: +17.04%
Spyre Therapeutics
Jun 30, 2026
Maintained: Buy
Price Target: $98
Current: $100.23
Upside: -2.22%
BioNTech SE
Jun 1, 2026
Maintained: Buy
Price Target: $138
Current: $91.48
Upside: +50.85%
Jade Biosciences
Jun 1, 2026
Maintained: Buy
Price Target: $16 → $40
Current: $20.86
Upside: +91.75%
May 22, 2026
Maintained: Buy
Price Target: $180
Current: $134.28
Upside: +34.05%
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $750.50
Upside: -
Apr 30, 2026
Maintained: Buy
Price Target: $14
Current: $3.69
Upside: +279.40%
Mar 11, 2026
Maintained: Buy
Price Target: $885 → $890
Current: $676.69
Upside: +31.52%
Mar 10, 2026
Initiated Coverage: Hold
Price Target: $350
Current: $366.29
Upside: -4.45%
Feb 19, 2026
Maintained: Buy
Price Target: $980 → $1,008
Current: $860.55
Upside: +17.13%
Dec 11, 2025
Maintained: Buy
Price Target: $50 → $46
Current: $55.92
Upside: -17.74%
Dec 5, 2025
Maintained: Buy
Price Target: $26 → $35
Current: $14.75
Upside: +137.29%
Nov 17, 2025
Maintained: Buy
Price Target: $13 → $42
Current: $24.19
Upside: +73.63%
Oct 1, 2025
Upgraded: Buy
Price Target: $18 → $20
Current: $13.74
Upside: +45.56%
Sep 3, 2025
Reiterated: Buy
Price Target: $70 → $80
Current: $80.18
Upside: -0.22%
Aug 12, 2025
Maintained: Buy
Price Target: $398 → $502
Current: $553.48
Upside: -9.30%
Jul 8, 2025
Maintained: Buy
Price Target: $86 → $96
Current: $134.00
Upside: n/a
Jun 18, 2025
Maintained: Buy
Price Target: $138
Current: $127.50
Upside: n/a
May 2, 2025
Downgraded: Hold
Price Target: $52 → $10
Current: $8.01
Upside: n/a
Apr 23, 2025
Maintained: Buy
Price Target: $70 → $68
Current: $60.74
Upside: n/a
Apr 1, 2025
Maintained: Buy
Price Target: $183
Current: $247.53
Upside: n/a
Jan 29, 2025
Maintained: Hold
Price Target: $6 → $2.5
Current: $5.11
Upside: n/a
Dec 11, 2024
Rated: Buy
Price Target: $16 → $17
Current: $19.91
Upside: n/a
Dec 12, 2022
Initiated Coverage: Buy
Price Target: $17
Current: $1.75
Upside: n/a
Feb 26, 2021
Downgraded: Hold
Price Target: n/a
Current: $17.29
Upside: n/a
Jan 29, 2020
Downgraded: Hold
Price Target: n/a
Current: $6.78
Upside: n/a
Jul 19, 2019
Initiated Coverage: Hold
Price Target: $9
Current: $32.03
Upside: n/a